This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Prins, K. C.
Right arrow Articles by Basler, C. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Prins, K. C.
Right arrow Articles by Basler, C. F.

 Previous Article  |  Next Article 

Journal of Virology, April 2009, p. 3069-3077, Vol. 83, No. 7
0022-538X/09/$08.00+0     doi:10.1128/JVI.01875-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Ebola Virus Protein VP35 Impairs the Function of Interferon Regulatory Factor-Activating Kinases IKK{varepsilon} and TBK-1{triangledown}

Kathleen C. Prins,{dagger} Washington B. Cárdenas,{dagger},{ddagger} and Christopher F. Basler*

Department of Microbiology, Mount Sinai School of Medicine, New York, New York 10029

Received 5 September 2008/ Accepted 7 January 2009

The Ebola virus (EBOV) VP35 protein antagonizes the early antiviral alpha/beta interferon (IFN-{alpha}/β) response. We previously demonstrated that VP35 inhibits the virus-induced activation of the IFN-β promoter by blocking the phosphorylation of IFN-regulatory factor 3 (IRF-3), a transcription factor that is crucial for the induction of IFN-{alpha}/β expression. Furthermore, VP35 blocks IFN-β promoter activation induced by any of several components of the retinoic acid-inducible gene I (RIG-I)/melanoma differentiation-associated gene 5 (MDA-5)-activated signaling pathways including RIG-I, IFN-β promoter stimulator 1 (IPS-1), TANK-binding kinase 1 (TBK-1), and I{kappa}B kinase epsilon (IKK{varepsilon}). These results suggested that VP35 may target the IRF kinases TBK-1 and IKK{varepsilon}. Coimmunoprecipitation experiments now demonstrate physical interactions of VP35 with IKK{varepsilon} and TBK-1, and the use of an IKK{varepsilon} deletion construct further demonstrates that the amino-terminal kinase domain of IKK{varepsilon} is sufficient for interactions with either IRF-3 or VP35. In vitro, either IKK{varepsilon} or TBK-1 phosphorylates not only IRF-3 but also VP35. Moreover, VP35 overexpression impairs IKK{varepsilon}-IRF-3, IKK{varepsilon}-IRF-7, and IKK{varepsilon}-IPS-1 interactions. Finally, lysates from cells overexpressing IKK{varepsilon} contain kinase activity that can phosphorylate IRF-3 in vitro. When VP35 is expressed in the IKK{varepsilon}-expressing cells, this kinase activity is suppressed. These data suggest that VP35 exerts its IFN-antagonist function, at least in part, by blocking necessary interactions between the kinases IKK{varepsilon} and TBK-1 and their normal interaction partners, including their substrates, IRF-3 and IRF-7.


* Corresponding author. Mailing address: Department of Microbiology, Box 1124, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY 10029. Phone: (212) 241-4847. Fax: (212) 534-1684. E-mail: basler{at}mssm.edu

{triangledown} Published ahead of print on 19 January 2009.

{dagger} K.C.P. and W.B.C. contributed equally.

{ddagger} Present address: Laboratorio de Biomedicina, FIMCM, ESPOL, P.O. Box 09-01-5863, Guayaquil, Ecuador.


Journal of Virology, April 2009, p. 3069-3077, Vol. 83, No. 7
0022-538X/09/$08.00+0     doi:10.1128/JVI.01875-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Schumann, M., Gantke, T., Muhlberger, E. (2009). Ebola Virus VP35 Antagonizes PKR Activity through Its C-Terminal Interferon Inhibitory Domain. J. Virol. 83: 8993-8997 [Abstract] [Full Text]  
  • Siu, K.-L., Kok, K.-H., Ng, M.-H. J., Poon, V. K. M., Yuen, K.-Y., Zheng, B.-J., Jin, D.-Y. (2009). Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3{middle dot}TANK{middle dot}TBK1/IKK{epsilon} Complex. J. Biol. Chem. 284: 16202-16209 [Abstract] [Full Text]